Intravenous administration of antithrombin III induces indefinite survival of fully allogeneic cardiac grafts.
Aramaki
O
O
Department of Surgery, Nihon University, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo, Japan 173-8610.
Takayama
T
T
Yokoyama
T
T
Takano
S
S
Akiyama
Y
Y
Shibutani
S
S
Shirasugi
N
N
Kan
S
S
Ikeda
Y
Y
Niimi
M
M
D000818:Animals; D000990:Antithrombin III / Q000008:administration & dosage / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000096:biosynthesis; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D007275:Injections, Intravenous; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D013997:Time Factors; D014184:Transplantation, Homologous
D016207:Cytokines; D000990:Antithrombin III